Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-29

Clinical Trial Update: Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a microneedle patch for measles and rubella vaccination completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Measles and Rubella Vaccine Microneedle Patch

Snippet

Sponsor: Micron Biomedical, Inc | Conditions: Measles, Rubella | Phase 1, Phase 2 | Status: COMPLETED